key: cord-0704544-lgvligor authors: Scott, Hayley; Zahra, Aleena; Fernandes, Rafael; Fries, Bettina C.; Thode, Henry C.; Singer, Adam J. title: Bacterial infections and death among patients with Covid-19 versus non Covid-19 patients with pneumonia date: 2021-09-28 journal: Am J Emerg Med DOI: 10.1016/j.ajem.2021.09.040 sha: f924e49bbbadf0db00aa6f070f82863159795860 doc_id: 704544 cord_uid: lgvligor BACKGROUND: Many patients with Coronavirus disease-2019 (Covid-19) present with radiological evidence of pneumonia. Because it is difficult to determine co-existence of bacterial pneumonia, many of these patients are initially treated with antibiotics. We compared the rates of bacterial infections and mortality in Covid-19 patients with pulmonary infiltrates versus patients diagnosed with ‘pneumonia’ the year previously. METHODS: We conducted a medical record review of patients admitted with Covid-19 and a pulmonary infiltrate and compared them with patients diagnosed with pneumonia admitted in the prior year before the pandemic. Data abstracted included baseline demographics, comorbidities, signs and symptoms, laboratory and microbiological results, and imaging findings. Outcomes were bacterial infections and mortality. Patients presenting with and without Covid-19 were compared using univariable and multivariable analyses. RESULTS: There were 1398 and 1001 patients admitted through the emergency department (ED) with and without Covid-19 respectively. Compared with non-Covid-19 patients, those with Covid-19 were younger (61±18 vs. 65±25 years, P < 0.001) and had a lower Charlson Comorbidity Index (0.7 vs. 1.2, P < 0.001). Bacterial infections were present in fewer Covid-19 than non-Covid-19 patients (8% vs. 13%, P < 0.001), and most infections in Covid-19 were nosocomial as opposed to community acquired in non-Covid-19 patients. CXR was more often read as abnormal and with bilateral infiltrates in patients with Covid-19 (82% vs. 70%, P < 0.001 and 81% vs. 48%, P < 0.001, respectively). Mortality was higher in patients with Covid-19 vs. those without (15% vs. 9%, P < 0.001). Multivariable predictors (OR [95%CI]) of mortality were age (1.04 [1.03–1.05]/year), tachypnea (1.55 [1.12–2.14]), hypoxemia (2.98 [2.04–4.34]), and bacterial infection (2.80 [1.95–4.02]). Compared with non-Covid-19 patients with pneumonia, patients with Covid-19 were more likely to die (2.68 [1.97–3.63]). CONCLUSIONS: The rate of bacterial infections is lower in Covid-19 patients with pulmonary infiltrates compared with patients diagnosed with pneumonia prior to the pandemic and most are nosocomial. Mortality was higher in Covid-19 than non-Covid-19 patients even after adjusting for age, tachypnea, hypoxemia, and bacterial infection. First reported in December 2019, SARS-CoV-2, the etiologic agent of the novel coronavirus infectious disease 2019 (Covid- 19) , has been responsible for the greatest pandemic in over a century. Covid-19 results in a wide spectrum of disease from asymptomatic carriers through pneumonia, Acute Respiratory Distress Syndrome (ARDS) and death leading to many hospitalizations and ICU admissions [1] . In the hospital as part of the work up, biological specimens (such as blood and sputum) are sent for microbiological culture to determine the presence of coexisting, or superimposed bacterial infections in patients diagnosed with Covid-19. To date, data on the prevalence of bacterial superinfection in Covid-19 positive patients is not well established [2] [3] [4] . Historically, patients hospitalized for influenza and influenza-like viral syndromes have been shown to be more susceptible to bacterial super-infection [5] . In the last 20 years, the world has experienced at least six major viral epidemics, including SARS-CoV, MERS, H1N1, Ebola, Zika, and the current SARS-CoV-2. Bacterial super-infections during these viral illnesses have been associated with poor outcomes [6] [7] [8] . Thus, bacterial superinfection is a poor prognostic factor for patients and 2009 H1N1 influenza pandemic that between 29 and 55% of deaths were due to secondary bacterial infections. Of five studies done during the original 2002 SARS-CoV outbreak, 11% of cases were associated with secondary bacterial infections [6] . Staphylococcus aureus, in particular, has been shown to be isolated from hospitalized patients with influenza virus infection [9, 10] . Streptococcus pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter and Citrobacter spp., and Haemophilus influenzae are also common bacteria isolated from blood and sputum cultures in patients with a bacterial superinfection on top of a respiratory viral infection [2, 3, 5, 8] . The goal of the current study was to determine the rate of coexistent bacterial infections in admitted patients with Covid-19 and a pulmonary infiltrate and compare it to the rate of bacterial infections in a control cohort of patients admitted with a diagnosis of pneumonia in the year prior to the Covid-19 pandemic. We also sought to establish if Covid-19 and bacterial infection were independently associated with increased mortality. We performed a structured, retrospective electronic medical record review (Cerner, Kansas City, MO) examining all patients presenting to our ED with confirmed Covid-19 based on a positive SARS-CoV-2 PCR. This study followed the Strengthening of Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines for crosssectional studies [11] . We also followed the recommended methodology of Kaji et al. for retrospective chart reviews [12] . Due to the retrospective nature of this study, we received IRB approval with waiver of informed consent. All patients admitted to our hospital between 2/2020-5/2020 with SARs-CoV-2 PCR confirmed Covid-19 infection were included in the study. For the control group, we used a cohort of all patients admitted to the hospital between 2/2019 and 5/2019 with a diagnosis of pneumonia based on International Classification of Diseases version 10 (ICD-10) codes. We specifically excluded patients with an ICD-10 code consistent with a viral pneumonia. We chose patients from the previous year prior to the pandemic with a diagnosis of pneumonia as the control group since many such patients have a pulmonary infiltrate and have traditionally presumed to have a bacterial etiology and started on antibiotics. Our hospital is a tertiary academic medical center with 650 hospital beds located in Eastern Long-Island approximately 60 miles from New York City, with a catchment area of 1.5 million inhabitants. A computerized search and a manual retrospective chart review of our electronic medical records to identify patients meeting all inclusion criteria was performed. For eligible patients, we extracted patient demographic information, including race, ethnicity, sex, comorbidities (expressed as a Charlson Comorbidity Index [CCI]), symptoms, vital signs, lab results, bacterial cultures and antigens, chest XR and chest CT imaging results, disposition, (discharge to home, admission to a non-intensive floor, admission to an ICU), and survival to hospital discharge. Study data and variables were defined prior to initiating the study and extracted by trained abstractors using a library of definitions. We periodically monitored data collection and determined the interobserver agreement on the outcomes on a randomly selected sample of 200 study patients. Interobserver agreement (Kappa statistic) ranged from 0.96 (95%CI, 0.90-0.99) to 1.0. The primary outcome was the presence of a culture or antigen confirmed bacterial infection. Secondary outcomes were in-hospital mortality, ICU admission, and hospital length of stay. All results of blood, sputum, and pleural bacterial cultures as well as urinary bacterial antigens were reviewed by a two-member committee including an emergency medicine and infectious disease provider to determine whether the positive cultures or antigens were 'true positives' and due to infection. Infections were defined as nosocomial if the positive culture was obtained >48 h after hospital admission. Patients with a first positive culture within 48 h who were admitted from home or from long term care facilities were deemed to have community-acquired infections. A patient with a positive culture was classified as an infection if the bacteria was isolated from blood or any other sterile source (e.g., pleural). Blood cultures with coagulase negative Staphylococcus species, Corynebacterium, or Bacillus (not anthracis) species were deemed to be contaminants from commensal skin flora [13] . For patients with positive sputum cultures, we required sputum samples to exhibit <9 epithelial cells per high power field and moderate-many WBCs to indicate infection. Sputum samples with more epithelial cells were deemed to represent inadequate sample collection. If no-few WBCs were present, we deemed positive bacterial cultures to represent colonization [13, 14] . However, if the same bacterial species was also isolated in sterile site cultures (blood or pleural fluid), then sputum cultures were classified as infection. These definitions were consistent with those proposed from IDSA/ATS Society guidelines [14] . Data are summarized as numbers and frequencies for nominal data and means with standard deviations (SD) for continuous data. For all variables and models, we only used the initial findings at ED presentation. Comparisons between groups were performed using logistic regression. Exploratory multivariate analysis of primary and secondary outcomes was performed using potential predictor variables chosen based on biological plausibility and previous reports. Variables significantly associated with outcomes on bivariable analyses were also entered into the model. Level of significance was defined as a P value of 0.05 or less. The study cohort included 1389 patients who were admitted through the ED with PCR confirmed Covid-19 infection between February and May 2020. The total number of ED visits during this time period was 25 , and were more likely to present with fever (22% vs. 9%), hypoxemia defined as oxygen saturation less than 94% (40% vs. 31%), leukopenia (9% vs. 5%), abnormal chest X-rays (82% vs. 70%), and bilateral findings both on chest X-rays (81% vs. 48%) and chest CT (87 vs. 63%) respectively; P < 0.001 for all comparisons. In contrast, patients with non-Covid-19 pneumonia were more likely than patients with Covid-19 to present with elevated creatinine (24% vs. 19%), elevated procalcitonin (33% vs 19%), and elevated cardiac troponin (18% vs. 10%) respectively; P < 0.001 for all comparisons. Bodily fluid (blood, sputum, and pleural) cultures and urinary antigens were tested in 1325 (95%) Covid-19 patients and 859 (89%) non-Covid-19 patients respectively (Table 2) . Positive results consistent with bacterial infections were found in a higher proportion of patients with non-Covid-19 pneumonia than in patients with Covid-19 (129 [13%] vs. 117 [8%] respectively, P < 0.001). A summary of the respective bacterial species identified in the study and control patients is presented in Table 3 . Patients with non-Covid-19 pneumonia presented with bacterial infections significantly earlier in their hospital course than patients with Covid-19. Median (IQR) days from admission to positive blood and sputum cultures in control and Covid-19 patients were 0 (0-1) vs. 12.5 (0 −21) and 1 (0-2) vs. 10 (7-19) respectively, P < 0.001 for both. Gram positive organisms represented the majority of infections found in our study in both the blood and sputum cultures. Among gram positive bacteria, Staphylococcus aureus was the predominant isolate both in non-Covid-19 and Covid-19 patients (Table 3) . Among gram negative bacteria Pseudomonas aeruginosa was the predominant isolate from non-Covid-19 patients while Klebsiella pneumoniae and Pseudomonas aeruginosa were the predominate species in Covid-19 patients (Table 3) . The number (%) of deaths was higher in Covid-19 patients than control patients without Covid-19; 211 (15%) vs. 86 (9%) respectively, P < 0.001 (Table 4) . A summary of the multivariable analyses is presented in Table 5 . Predictor variables associated with death after adjusting for confounding variables (OR, 95%CI) were age (1.04, 1.03-1.05/year), tachypnea (1.55, 1.12-2.14), and oxygen saturation less than 89% (2.98-2.04-4.34). Presence of a bacterial infection (2.80, 1.95-4.02) and Covid-19 (2.68, 1.97-3.63) were independently associated with mortality even after adjusting for confounders. The number (%) of patients who required ICU level of care among patients with and without Covid-19 was 327 (24%) vs. 275 (27%) Values are presented as number (%) or mean (standard deviation). Mean total hospital length of stay did not differ between the two study groups based on univariable analysis (Table 4 ). Predictor variables associated with prolonged length of stay after adjusting for confounding variables included oxygen saturation less than 89%<, ICU admission, and bacterial infection (Table 5 ). In this retrospective study we compared a cohort of admitted patients with Covid-19 during 2020 and another cohort of admitted patients with non-Covid-19 pneumonia in 2019. We found that non-Covid-19 patients with pneumonia were more likely to have a bacterial infection than Covid-19 patients and were more likely to present with a community acquired infection on arrival to the hospital. In contrast, Covid-19 patients were less likely to present with evidence of bacterial infection and when bacterial infection was evident, it was more likely to be nosocomial occurring later in the hospital admission. This suggests that bacterial superinfection occurred in the majority of Covid-19 patients. Given the appearance of bacteremia later in the hospital course of Covid-19 patients, line infection with skin flora translocation to the bloodstream is a possible likely etiology in many patients. This is similar to other respiratory viral infections such as influenza, in which superinfection is not uncommon, particularly with Staph. aureus [9, 10] . Not surprisingly, we also found that the evidence of a bacterial coinfection was independently associated with mortality both in patients with and without Covid-19. Another possible explanation for the reduced rates of bacterial co-infection during the Covid-19 study period is the widespread use of masks and social distancing that may have further reduced bacterial co0infections and superinfections. Evidence of bacterial infection based on blood, sputum and pleural bacterial cultures as well as urinary antigens was only present in 13% of those with non-Covid-19 pneumonia that were tested. This is consistent with prior similar studies in which positive blood cultures have been reported in 5-14% of those tested [15, 16] . Prior studies have found that Strep. pneumoniae is the most common bacterial etiology of pneumonia [16] . However, in our study other less typical bacteria were commonly found such as Staph. aureus, both in patients with and without Covid-19. Studies have shown that infection with SARS-CoV-2 can lead to an impairment in immune function by damaging lymphocytes, especially B cells, T cells, and NK cells [17] . This decrease in immune function likely contributes to increased susceptibility to bacterial coinfection [18] . Our study is unique in that it directly compared patients with non-Covid-19 pneumonia who did not have a confirmed diagnosis of viral infection with patients with a confirmed diagnosis of Covid-19. A study preceding the Covid-19 pandemic found that among patients infected with other respiratory viruses, the number of cases of primary coinfection or secondary bacterial pneumonia was between 11 and 35% [19] . Another study from 2003, reported that more than 20% of the patients who were positive for SARS-CoV had evidence of bacterial and fungal coinfection [20] . A single-center, retrospective case series study including 55 severe patients and 166 non-severe patients with laboratoryconfirmed SARS-CoV-2 pneumonia, found that in all 221 patients the bacterial coinfection rate was 7.7% [21] . A study from Italy that included 16,654 patients who died of SARS-CoV-2 infection, reported that 11% had coinfection [22] . A retrospective, single-center study of 99 Covid-19 cases from Wuhan reported coinfections with Acinetobacter baumannii and Klebsiella pneumoniae [23] . Regardless of the rate and cause of bacterial co-infections in patients with Covid-19, there is evidence that bacterial co-infection is proportional to the severity of the disease [24] , and that coinfection can increase the mortality [25] . Our study has several notable limitations. Due to its retrospective nature, we cannot exclude selection bias or residual confounding. While most patients were cultured, some were not. This may have underestimated the number of patients with bacterial infection. We also cannot exclude errors in data entry and reporting. We used commonly suggested criteria to distinguish between true bacterial infection and contamination [14] . However, these criteria may have overestimated or underestimated the true number of infections. In addition, our study is representative of a single, academic suburban hospital near one of the first epicenters of the Covid-19 pandemic and may not be representative of other settings. We found higher rates of bacterial infection in patients with non-Covid-19 pneumonia presenting in the year prior to the global Covid-19 pandemic than in Covid-19 patients presenting early in the pandemic. Of Covid-19 patients who developed bacterial infection many were nosocomial acquired after hospital admission and were caused by less common bacteria such as Staph. aureus and gram-negative bacteria. Routine administration of antibiotics to Covid-19 patients on admission, especially those without severe disease, does not seem warranted. None. Author contributions HS, BCF, and AJS conceived the study and designed the study. AJS and RF supervised the conduct of the study and data collection. HCT analyzed the data. HS and AJS drafted the manuscript and all authors contributed substantially to its revision. AJS takes responsibility for the paper as a whole. Hayley Scott: writing original-draft, data curation, formal anlysis analysis. Allena Zahra: formal analysis, writing-review & editing. Rafael Fernandes: supervision, data curation, writing-review & editing. Bettina Fries: conceptualization, formal analysis, writing-review & editing. Henry Thode: formal analysis. Adam Singer: conceptualization, formal analysis, writing-original draft, supervision. None of the authors have any conflicts of interest related to this study. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): a review The microbial coinfection in COVID-19 Assessment of respiratory bacterial coinfections among severe acute respiratory syndrome coronavirus 2-positive patients hospitalized in intensive care units using conventional culture and biofire, FilmArray Pneumonia Panel Plus Assay. Open Forum Infect Dis Bacterial coinfections with SARS-CoV-2. IUBMB Life Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality Secondary bacterial infections in patients with viral pneumonia Pneumonia with bacterial and viral coinfection Unit of Antibiotic Resistance and Special Pathogens; Unit of Antibiotic Resistance and Special Pathogens of the Department of Infectious Diseases, Istituto Superiore di Sanità, Rome. Bacterial coinfections in COVID-19: an underestimated adversary Staphylococcus aureus pneumonia: preceding influenza infection paves the way for low-virulent strains. Toxins (Basel) Molecular characterization of Staphylococcus aureus and influenza virus coinfections in patients with fatal Pneumonia Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration Looking through the retrospectoscope: reducing bias in emergency medicine chart review studies Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults Bacteremia prediction model using a common clinical test in patients with community-acquired pneumonia Microbiology etiology of pneumonia: epidemiology. Diagnosis and resistance patterns Case report: one case of coronavirus disease 2019 (COVID-19) in patient co-infected by HIV with a low CD4+ T cell count Combination of lymphocyte number and function in evaluating host immunity The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respi Viruses The clinical characteristics of secondary infections of lower respiratory tract in severe acute respiratory syndrome Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan COVID-19: don't neglect antimicrobial stewardship principles! Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?